Dr. Marcus to have e clinical letter published in SCIENCE Magazine

In December, Science magazine will publish my comments on the role of clinical trials and how they might be changed given the advancements of the information age and the requirements of “personalized medicine”.  It will not longer be sufficient, IMO, to conduct mass market trials that assume all patients are similar. This letter was written in response to a recent editorial on the subject by Andy Grove, former CEO of INTEL.